Cyclerion Therapeutics
CYCN
CYCN
40 hedge funds and large institutions have $13.7M invested in Cyclerion Therapeutics in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
25% less capital invested
Capital invested by funds: $18.3M → $13.7M (-$4.6M)
Holders
40
Holding in Top 10
–
Calls
$307K
Puts
$2K
Top Buyers
| 1 | +$32K | |
| 2 | +$16.7K | |
| 3 | +$12K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.66K |
Top Sellers
| 1 | -$210K | |
| 2 | -$80K | |
| 3 | -$65.2K | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$17K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$17K |